Michelle Olding and Lucas Martignetti talks about their respective research and Andrew Patterson shares his thoughts from his perspective as a physician who provides care to PWUD. Their discussion is followed by questions and discussion.
Also available:
Research papers discussed
Martignetti, L., et al. Motivations for and perspectives of medication diversion among clients of a safer opioid supply program in Toronto, Canada International Journal of Drug Policy. 2025; January. doi.org/10.1016/j.drugpo.2024.104665
Olding, M., et al. Perspectives on Diversion of Medications From Safer Opioid Supply Programs JAMA Netw Open. 2024 Dec 18;7(12):e2451988. doi: 10.1001/jamanetworkopen.2024.51988
Haines, M., et al. Safer supply programs: Discussions on medication diversion, sharing, and selling International Journal of Drug Policy. 2025; March. https://doi.org/10.1016/j.drugpo.2025.104731
Bowles, J., Ivsins, A., et al. Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs International Journal of Drug Policy. 2024; November. https://doi.org/10.1016/j.drugpo.2024.104601
Socias, M.E, et al. The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada. 2021 Nov 1:228:109109. doi: 10.1016/j.drugalcdep.2021.109109.
National Safer Supply Community of Practice. Reframing Diversion: FAQ for Health Care Providers. Canada. https://www.nss-aps.ca/safer-supply-prescribers-faq
